Gamze Karatas

Okmeydani, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Real-world evaluation of anti-VEGF therapy in diabetic macular edema: The role of macular ischemia and OCT biomarkers BOSPHORUS DME study group report no: 14.

Real-world evaluation of anti-VEGF therapy in diabetic macular edema: The role of macular ischemia and OCT biomarkers BOSPHORUS DME study group report no: 14.

Journal: European journal of ophthalmology
Published: July 24, 2026

Reply.

Reply.

Journal: Turkish journal of ophthalmology
Published: June 25, 2026

Intravitreal Faricimab for Retinal Vein Occlusion: Real-World Outcomes from the Multicenter FARTURK-RVO Study in Türkiye.

Intravitreal Faricimab for Retinal Vein Occlusion: Real-World Outcomes from the Multicenter FARTURK-RVO Study in Türkiye.

Journal: Ophthalmology and therapy
Published: May 20, 2026

Correction: Real-World 6-Month Treatment Outcomes of Faricimab in Turkey: The FARTURK Study.

Correction: Real-World 6-Month Treatment Outcomes of Faricimab in Turkey: The FARTURK Study.

Journal: Ophthalmology and therapy
Published: April 04, 2026

Association Between Autonomic Symptoms and the Choroidal Vascularity Index in Fibromyalgia Patients.

Association Between Autonomic Symptoms and the Choroidal Vascularity Index in Fibromyalgia Patients.

Journal: Medicina (Kaunas, Lithuania)
Published: March 07, 2026

Evaluation of anti-VEGF response in diabetic macular edema patients with baseline DRIL: a multicenter real-world study (BOSPHORUS-DME Study Group Report No.16).

Evaluation of anti-VEGF response in diabetic macular edema patients with baseline DRIL: a multicenter real-world study (BOSPHORUS-DME Study Group Report No.16).

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: February 21, 2026

Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Türkiye: 48-Month Data, BOSPHORUS-DME Study Group Report No. 1.

Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Türkiye: 48-Month Data, BOSPHORUS-DME Study Group Report No. 1.

Journal: Turkish journal of ophthalmology
Published: February 18, 2026

Long-Term Intravitreal Dexamethasone Implant Monotherapy in Naïve Patients with Diabetic Macular Edema.

Long-Term Intravitreal Dexamethasone Implant Monotherapy in Naïve Patients with Diabetic Macular Edema.

Journal: Turkish journal of ophthalmology
Published: February 18, 2026

Cost-effectiveness analysis of early versus late switching in treatment-naïve patients with refractory diabetic macular oedema in the Turkish population: real-world data from the Bosphorus DME study group, report number 5.

Cost-effectiveness analysis of early versus late switching in treatment-naïve patients with refractory diabetic macular oedema in the Turkish population: real-world data from the Bosphorus DME study group, report number 5.

Journal: Clinical & experimental optometry
Published: January 06, 2026

Real-World 6-Month Treatment Outcomes of Faricimab in Turkey: The FARTURK Study.

Real-World 6-Month Treatment Outcomes of Faricimab in Turkey: The FARTURK Study.

Journal: Ophthalmology and therapy
Published: December 30, 2025

Real-World 6-Month Treatment Outcomes of Faricimab in Turkey: The FARTURK Study.

Real-World 6-Month Treatment Outcomes of Faricimab in Turkey: The FARTURK Study.

Journal: Ophthalmology and therapy
Published: December 30, 2025

Effect of androgens on retinal microvasculature in prepubertal girls with isolated premature pubarche.

Effect of androgens on retinal microvasculature in prepubertal girls with isolated premature pubarche.

Journal: Journal of pediatric endocrinology & metabolism : JPEM
Published: December 02, 2025
Showing 1-12 of 29

Last Updated: 09/26/2026